NCT06169436 Translational Cancer Observational Protocol
| NCT ID | NCT06169436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Upper Urinary Tract Urothelial Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,250 participants |
| Start Date | 2014-07-17 |
| Primary Completion | 2064-07-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,250 participants in total. It began in 2014-07-17 with a primary completion date of 2064-07-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Upper tract urothelial cancer diagnosis * Indication to cancer removal through nephroureterectomy surgery * Ability to read and sign the informed consent Exclusion Criteria: * Age \< 18 years * Absence of upper tract urothelial cancer * Inability to read and sign the informed consent
Contact & Investigator
Francesco Montorsi, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06169436 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Upper Urinary Tract Urothelial Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06169436 currently recruiting?
Yes, NCT06169436 is actively recruiting participants. Contact the research team at montorsi.francesco@hsr.it for enrollment information.
Where is the NCT06169436 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06169436 clinical trial?
NCT06169436 is sponsored by IRCCS San Raffaele. The principal investigator is Francesco Montorsi, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 1,250 participants.